Chiasson J L, Liljenquist J E, Finger F E, Lacy W W
Diabetes. 1976 Apr;25(4):283-91. doi: 10.2337/diab.25.4.283.
The suppressive effect of insulin on hepatic glucose production is generally recognized. Though it is well established that this effect is at least partially due to inhibition of glycogenolysis, controversy still exists about insulin's effect on gluconeogenesis. The present study was undertaken to determine whether insulin could affect gluconeogenesis from alanine in the intact dog and to compare the effect of insulin on glycogenolysis and gluconeogenesis. In anesthetized dogs fasted overnight, blood samples were drawn simultaneously from a femoral artery and hepatic vein. Alanine-U-14C, 10 mu Ci./kg., was infused over 110 minutes. A constant insulin infusion at either 1 or 5 mU./kg./min. was begun at 50 minutes, and blood glucose concentration was maintained by a variable glucose infusion. When insulin was infused at 1 mU./kg./min., resulting in plasma immunoreactive insulin (IRI) levels of 73 +/- 10 muU./ml., the net splanchnic glucose production (NSGP) was suppressed from 2.7 +/- 2 mg./kg./min. to virtually zero. In constrast, this small increment in insulin concentration had no demonstrable effect on the net splanchnic uptake of alanine or on the conversion of plasma alanine to glucose (7.9 +/- 0.3 mu mol/min.). Insulin infused at 5 mU./kg./min. resulted in IRI levels of 240 +/- 25 muU./ml. This higher insulin concentration was associated with a marked suppression of both the NSGP (100 per cent) and the conversion of plasma alanine to glucose (90 per cent) but did not affect the extraction of alanine by the splanchnic bed. Doses of both 1 and 5 mU./kg./min. were associated with a 35 per cent fall in immunoreactive glucagon levels. These data demonstrate that (1) glycogenolysis is more sensitive than gluconeogenesis to the inhibitory effect of small increments in insulin concentrations, (2) gluconeogenesis could be suppressed by insulin but only at higher insulin concentrations, (3) this suppression of gluconeogenesis from alanine by insulin was due to an intrahepatic effect rather than an effect on the splanchnic extraction of alanine, and finally, (4) that insulin can suppress glucagon in the absence of hyperglycemia.
胰岛素对肝脏葡萄糖生成的抑制作用已得到普遍认可。尽管已充分证实这种作用至少部分是由于糖原分解受到抑制,但关于胰岛素对糖异生的作用仍存在争议。本研究旨在确定胰岛素是否会影响完整犬体内丙氨酸的糖异生,并比较胰岛素对糖原分解和糖异生的作用。在禁食过夜的麻醉犬中,同时从股动脉和肝静脉采集血样。以10μCi./kg.的剂量在110分钟内输注丙氨酸 - U - 14C。在50分钟时开始以1或5mU./kg./min.的速率持续输注胰岛素,并通过可变葡萄糖输注维持血糖浓度。当以1mU./kg./min.的速率输注胰岛素时,血浆免疫反应性胰岛素(IRI)水平达到73±10μU./ml,内脏葡萄糖净生成量(NSGP)从2.7±2mg./kg./min.降至几乎为零。相比之下,胰岛素浓度的这一微小升高对丙氨酸的内脏净摄取或血浆丙氨酸向葡萄糖的转化(7.9±0.3μmol/min.)没有明显影响。以5mU./kg./min.的速率输注胰岛素时,IRI水平达到240±25μU./ml。这种较高的胰岛素浓度与NSGP(100%)和血浆丙氨酸向葡萄糖的转化(90%)的显著抑制相关,但不影响内脏床对丙氨酸的摄取。1和5mU./kg./min.的剂量均与免疫反应性胰高血糖素水平下降35%相关。这些数据表明:(1)糖原分解比糖异生对胰岛素浓度微小升高的抑制作用更敏感;(2)胰岛素可抑制糖异生,但仅在较高胰岛素浓度时;(3)胰岛素对丙氨酸糖异生过程的这种抑制作用是由于肝内效应而非对内脏摄取丙氨酸的影响;最后,(4)在无高血糖情况下胰岛素可抑制胰高血糖素。